Abstract:Stroke is a life-threatening medical condition and is a leading cause of disability. Cerebral ischemia is characterized by a distinct inflammatory response starting with the production of various cytokines and other inflammation-related agents. Progranulin (PGRN), a multifunctional protein, is critical in diverse physiological reactions, such as cell proliferation, inflammation, wound healing, and nervous system development. A mature PGRN is anti-inflammatory, while granulin, its derivative, conversely induces pro-inflammatory cytokine expression. PGRN is significantly involved in the brain tissue and its damage, for example, improving mood and cognitive disorders caused by cerebral ischemia. It may also have protective effects against nerve and spinal cord injuries by inhibiting neuroinflammatory response and apoptosis or it may be related to the proliferation, accumulation, differentiation, and activation of microglia. PGRN is a neurotrophic factor in the central nervous system. It may increase post-stroke neurogenesis of the subventricular zone (SVZ), which is particularly important in improving long-term brain function following cerebral ischemia. The neurogenesis enhanced via PGRN in the ischemic brain SVZ may be attributed to the induction of PI3K/AKT and MAPK/ERK signaling routes. PGRN can also promote the proliferation of neural stem/progenitor cells through PI3K/AKT signaling pathway. PGRN increases hippocampal neurogenesis, reducing anxiety and impaired spatial learning post-cerebral ischemia. PGRN alleviates cerebral ischemia/reperfusion injury by reducing endoplasmic reticulum stress and suppressing the NF-κB signaling pathway. PGRN can be introduced as a potent neuroprotective agent capable of improving post-ischemia neuronal actions, mainly by reducing and elevating the inflammatory and anti-inflammatory cytokines. Expression, storage, cleavage, and function of progranulin (PGRN) in the pathogenesis of ischemic stroke.

Progranulin Protects Against Renal Ischemia/reperfusion Injury in Mice.

Progranulin protects against renal ischemia|[sol]|reperfusion injury in mice

Progranulin Protects Against Endotoxin-Induced Acute Kidney Injury by Downregulating Renal Cell Death and Inflammatory Responses in Mice

Progranulin Protects Against Cerebral Ischemia-Reperfusion (I/R) Injury by Inhibiting Necroptosis and Oxidative Stress.

Progranulin deficiency attenuates tubulointerstitial injury in a mouse unilateral ureteral obstruction model

Pretreatment with Granulocyte Colony‐stimulating Factor Attenuated Renal Ischaemia and Reperfusion Injury Via Activation of PI3/Akt Signal Pathway

Neuroprotective Effects of Progranulin in Ischemic Mice.

Progranulin promotes functional recovery and neurogenesis in the subventricular zone of adult mice after cerebral ischemia

Therapeutic Potential of Progranulin in Hyperhomocysteinemia-Induced Cardiorenal Dysfunction.

Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis

Prevention of LPS-induced acute lung injury in mice by progranulin.

Progranulin Ameliorates Lung Inflammation in an LPS-induced Acute Lung Injury Mouse Model by Modulating Macrophage Polarization and the MAPK Pathway

PGRN Acts As a Novel Regulator of Mitochondrial Homeostasis by Facilitating Mitophagy and Mitochondrial Biogenesis to Prevent Podocyte Injury in Diabetic Nephropathy

Progranulin Protects Against Amyloid Β Deposition and Toxicity in Alzheimer’s Disease Mouse Models

Progranulin in Regulation Mechanism of Glycolipid Metabolism and Renal Disease

Progranulin alleviates podocyte injury via regulating CAMKK/AMPK-mediated autophagy under diabetic conditions

PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner

The Role of Progranulin (PGRN) in the Pathogenesis of Ischemic Stroke

Progranulin Improves Acute Lung Injury through Regulating the Differentiation of Regulatory T Cells and Interleukin-10 Immunomodulation to Promote Macrophage Polarization

Gene deficiency or pharmacological inhibition of PDCD4-mediated FGR signaling protects against acute kidney injury

Progranulin: A promising biomarker and therapeutic target for fibrotic diseases